Jose E Tanus-Santos
Jose E Tanus-Santos
Verified email at
Cited by
Cited by
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
CD Reiter, X Wang, JE Tanus-Santos, N Hogg, RO Cannon, ...
Nature medicine 8 (12), 1383-1389, 2002
A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs
F Barbosa Jr, JE Tanus-Santos, RF Gerlach, PJ Parsons
Environmental health perspectives 113 (12), 1669-1674, 2005
Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants
JE Tanus-Santos, M Desai, DA Flockhart
Pharmacogenetics and Genomics 11 (8), 719-725, 2001
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre …
RD Lopes, RHM Furtado, AVS Macedo, B Bronhara, LP Damiani, ...
The Lancet 397 (10291), 2253-2263, 2021
Circulating interleukin‐6 and high‐sensitivity C‐reactive protein decrease after periodontal therapy in otherwise healthy subjects
AM Marcaccini, CA Meschiari, CA Sorgi, MCP Saraiva, AM de Souza, ...
Journal of periodontology 80 (4), 594-602, 2009
Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
VC Sandrim, ACT Palei, IF Metzger, VA Gomes, RC Cavalli, ...
Hypertension 52 (2), 402-407, 2008
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
MM Castro, E Rizzi, L Figueiredo-Lopes, K Fernandes, LM Bendhack, ...
Atherosclerosis 198 (2), 320-331, 2008
Gingival crevicular fluid levels of MMP‐8, MMP‐9, TIMP‐2, and MPO decrease after periodontal therapy
AM Marcaccini, CA Meschiari, LR Zuardi, TS De Sousa, M Taba Jr, ...
Journal of clinical periodontology 37 (2), 180-190, 2010
Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms
AS Marroni, IF Metzger, DC Souza-Costa, S Nagassaki, VC Sandrim, ...
Nitric Oxide 12 (3), 177-182, 2005
Biological activity of nitric oxide in the plasmatic compartment
X Wang, JE Tanus-Santos, CD Reiter, A Dejam, S Shiva, RD Smith, ...
Proceedings of the National Academy of Sciences 101 (31), 11477-11482, 2004
Implications of cytochrome P450 interactions when prescribing medication for hypertension
DA Flockhart, JE Tanus-Santos
Archives of internal medicine 162 (4), 405-412, 2002
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
MM Castro, E Rizzi, GJ Rodrigues, CS Ceron, LM Bendhack, RF Gerlach, ...
Free Radical Biology and Medicine 46 (9), 1298-1307, 2009
Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension
MF Montenegro, JH Amaral, LC Pinheiro, EK Sakamoto, GC Ferreira, ...
Free Radical Biology and Medicine 51 (1), 144-152, 2011
Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms
GH Oliveira-Paula, R Lacchini, JE Tanus-Santos
Gene 575 (2), 584-599, 2016
Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol
JE Tanus-Santos, M Desai, LR Deak, JC Pezzullo, DR Abernethy, ...
Pharmacogenetics and Genomics 12 (5), 407-413, 2002
Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
IF Metzger, JTC Sertório, JE Tanus-Santos
Free Radical Biology and Medicine 43 (6), 987-992, 2007
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma
RF Gerlach, C Demacq, K Jung, JE Tanus-Santos
Clinical biochemistry 40 (1-2), 119-123, 2007
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and …
ACT Palei, VC Sandrim, RC Cavalli, JE Tanus-Santos
Clinical biochemistry 41 (10-11), 875-880, 2008
Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
RF Gerlach, JA Uzuelli, CD Souza-Tarla, JE Tanus-Santos
Analytical biochemistry 344 (1), 147-149, 2005
Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
CD Souza-Tarla, JA Uzuelli, AA Machado, RF Gerlach, JE Tanus-Santos
Clinical biochemistry 38 (5), 410-414, 2005
The system can't perform the operation now. Try again later.
Articles 1–20